0000899866-17-000133.txt : 20170609 0000899866-17-000133.hdr.sgml : 20170609 20170609183431 ACCESSION NUMBER: 0000899866-17-000133 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170607 FILED AS OF DATE: 20170609 DATE AS OF CHANGE: 20170609 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ALEXION PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000899866 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133648318 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 COLLEGE STREET CITY: NEW HAVEN STATE: CT ZIP: 06510 BUSINESS PHONE: 2032722596 MAIL ADDRESS: STREET 1: 100 COLLEGE STREET CITY: NEW HAVEN STATE: CT ZIP: 06510 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ORLOFF JOHN J CENTRAL INDEX KEY: 0001643941 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-27756 FILM NUMBER: 17904087 MAIL ADDRESS: STREET 1: C/O BAXALTA INCORPORATED STREET 2: 1200 LAKESIDE DRIVE CITY: BANNOCKBURN STATE: IL ZIP: 60015 4 1 wf-form4_149704765549250.xml FORM 4 X0306 4 2017-06-07 0 0000899866 ALEXION PHARMACEUTICALS INC ALXN 0001643941 ORLOFF JOHN J C/A ALEXION PHARMACEUTICALS, INC 100 COLLEGE STREET NEW HAVEN CT 06510 0 1 0 0 EVP, Research & Development Common Stock, par value $.0001 per share 2017-06-07 4 A 0 24965 0 A 24965 D Award of Restricted Stock Units under the 2017 Incentive Plan. 25% vest on each anniversary of the grant date. /s/ Michael V. Greco, Attorney-in-Fact for John Orloff 2017-06-09